#elite athletic training

Discover 3 curated intelligence briefings related to this specific topic.

The Sarcopenia Shadow: Ozempic's Lean Mass Tax
Science & Health

The Sarcopenia Shadow: Ozempic's Lean Mass Tax

The weight is vanishing, but the machinery is failing. An intel report on the unseen secondary effect of GLP-1 agonists: the systemic liquidation of skeletal muscle.

Read Analysis
The Lean Mass Paradox: Inside the Race to Save Muscle in the GLP-1 Era
Health & Medicine

The Lean Mass Paradox: Inside the Race to Save Muscle in the GLP-1 Era

The gold rush of GLP-1 agonists has delivered unprecedented weight loss, but at a hidden cost. We investigate the 'Muscle Gap' and the pharmaceutical pivot toward muscle-sparing therapies to prevent a global surge in iatrogenic sarcopenia.

Read Analysis
Why the World's Elite Athletes Are Looking Toward Central Asia
Sports

Why the World's Elite Athletes Are Looking Toward Central Asia

The shift of Central Asia from a mere logistics corridor to a strategic EU partner is creating a new ecosystem for elite athletic development, exemplified by the rise of global stars like Elena Rybakina.

Read Analysis